Mental Health & Substance Abuse Management Summit
Best Practices and Innovations in Mental Health and Wellness for Providers, Health Plans and Employers
October 26 – 27, 2020 * Orlando, FL

Mental Health & Substance Abuse Management Summit

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

About the Conference

Millions of people in the U.S. are affected by mental illness each year. Mental health illness and substance use disorders affect people of all ages and demographics and are extremely burdensome to society and socioeconomic costs. More than one in four adults living with serious mental health problems also has a substance use problem. Because of this, behavioral health integration and management has moved to the forefront as the healthcare industry strives to advance the coordination of behavioral healthcare services and implementation of integration initiatives to improve access to treatment.

This conference will bring together some of the leading national experts responding to this ever-increasing public health crisis to provide insights on policy, operations, and management of mental health strategies to reduce the impact of mental and substance use disorders on America’s communities. Join your peers to shape the future of mental health and hear how to address the opioid epidemic, collaboration with community partners, treating co-occurring disorders, value-based care, workplace wellness, social determinants and more.

Who Should Attend?

From Hospitals/Health Systems/Health Plans/Gov’t Agencies/Psychiatrists/Employers/Law Enforcement/Education Facilities/Rehab Facilities/Counseling Centers

  • CEO
  • CFO
  • VP
  • Medical Directors
  • Behavioral Health Directors
  • Pharmacy Directors
  • Clinical Pharmacists
  • Mental Health Counselors
  • Social Workers
  • Outreach Coordinators
  • PDMP Directors
  • Pain Management Directors
  • Psychiatrists
  • Psychologists
  • Telehealth Directors
  • State Health Directors
  • Nursing Director
  • Employee Assistance Programs
  • HR/Benefits
  • Emergency Room Directors
  • Substance Abuse & Prevention Directors
  • Pediatricians
  • Law Enforcement
  • Narcotic Enforcement
  • Physicians
  • Quality Improvement Director
  • Occupational Health
  • Family Services Director
  • Clinical Directors
  • Investigators
  • Compliance Director
  • Correctional Coordinators

This Event Will Also be if Interest to:

  • Pharmaceutical Companies * Law Firms * Consultants * Drug Development Companies

Conference Agenda

Day One – Monday, October 26, 2020

7:15am – 8:00am
Conference Registration & Networking Breakfast

8:00am – 8:15am
Chairperson’s Opening Remarks

8:15am – 9:00am
Improving Access to Mental Health and Substance Use Care and Ensuring Network Adequacy

Employers, health plans and other key stakeholders all have key roles to play in improving access to mental health and substance use care. The key barriers to improving well-being and health outcomes for people who have mental health conditions need to be addressed. These include a fragmented care system; an undersized, poorly distributed and underprepared workforce; and payment models that reinforce care silos and fragmentation of care. This session will examine resolutions to these challenges, including:

- Payment models that support service integration
- How train a workforce skilled in managing mental health and substance abuse in the context of integrated care
- Developing incentives to disseminate tested organizational models and create new approaches

9:00am – 9:45am
Collaboration Between Opioid Treatment Programs and Community Partners

In response to the heightened risks associated with the use of opioids, this session will discuss community safety strategies to reduce the harm imposed by opioids on communities and help to control the opioid epidemic. Topics will include:

- Best practice in opioid prescribing and monitoring to reduce the quantity of opioids in circulation
- Strategies to assist healthcare partnerships and collaborations by advancing their understanding of medication assisted treatment as a crucial element to community wellness in an era of healthcare reform
- The essential role that the community plays in recovery support and prevention

9:45am – 10:15am
Networking & Refreshments Break

10:15am – 11:00am
Scope of the Opioid Epidemic

This presentation will review “The Perfect Storm,” which resulted in the opioid epidemic in the United States. The relationship between prescription opioids, then heroin, and now fentanyl will be described. Evidence for both the effectiveness and safety of chronic opioid therapy to treat chronic non-cancer pain will be assessed. Intended and unintended consequences of the efforts to stem the tide of overdose deaths will be defined. Treatment strategies based on the CDC Guidelines for Treating Chronic Pain will be discussed.

11:00am – 11:45am
Meditate, Not Medicate Pain Away

The current opiate crisis has left both doctors and patients struggling and frustrated. Doctors around the country are struggling to follow FDA guidelines and state regulations restricting their ability to write prescriptions for their patients. Patients, on the other hand, are frustrated or worse because for thousands of them, the medications that were allowing them to function are suddenly being taken away, and they have been left to either find them on the street or suffer. Fortunately, there is increasing evidence that alternative treatment modalities may fill this gap. CBT, Mindfulness based therapies, CBT, acupuncture – these are some of these alternative treatment approaches that work to reduce pain and suffering without the risks associated with narcotics. This talk will focus on the use of tools to manage chronic pain and suffering.

11:45am – 12:30pm
The Opioid Crisis: Law Enforcement’s Evolving Role

Over the past few years, the role law enforcement has played in combatting the misuse of opioids and subsequent overdose deaths has evolved significantly. The acknowledgement that opioids must not only be treated as a public safety issue, but also as a public health crisis has led law enforcement to engage in non-traditional collaborative relationships. This session will discuss the multidisciplinary approach law enforcement, regulatory boards, the medical community and treatment professionals must engage in to reduce the abuse and negative outcomes associated with prescription opioids, heroin and illicit fentanyl abuse. This presentation will focus on strategies that have proven successful in creating effective partnerships to overcome the opioid epidemic.

12:30pm – 1:30pm
Lunch

1:30pm – 2:15pm
“Where’s the EZ button?”: Practical use of Data and Analytics to Improve Outcomes in Substance Abuse and Mental Health

Data and analytics are playing an ever-increasing role in both individual patient care and in population health management in all areas of healthcare, including substance abuse and mental health. Although today’s rapidly expanding computing power, availability of data sources, and “connectedness” make it possible to dramatically improve mental health and substance abuse care, it is essential that the data be delivered as actionable, clinically-useful information to improve clinical decision-making that results in real-world improvements in both preventative efforts and clinical outcomes. This session will discuss how technology advances in data analysis apply to the substance abuse and mental health fields and explore practical applications of various technologies to improve patient care and strengthen your substance abuse/mental health program.

2:15pm – 3:00pm
The Importance of Early Assessment and Treatment of Mental Illness

Mental illness has been viewed as a disease of early adulthood. But the onset of these illnesses typically occurs in teens and young adults. In fact, about half of all lifetime cases of mental illnesses start at age 14. Symptoms in three-quarters of mental illness cases appear by age 24. About one in 10 children and teens suffer from mental illness severe enough to cause some level of impairment. Early detection and treatment of mental disorders can result in a substantially shorter and less disabling course of illness. As the mental health field becomes increasingly able to identify the early antecedents of mental illnesses at any age, interventions must be implemented, provided in multiple settings, and connected to treatment and supports. This session will examine how early interventions and educational efforts can help a greater number of parents, the public, and providers learn about the importance of the first years of a child’s life and how to establish a foundation for healthy social and emotional development.

3:00pm – 3:30pm
Networking & Refreshments Break

3:30pm – 4:30pm
Panel: Integrated Treatment Plans for Dual Diagnosis

Mental disorders, such as depression, often accompany an addiction. When co-occurring disorders are present, the individual has a dual diagnosis. Many people diagnosed with a substance use disorder (SUD) also suffer from a co-occurring mental health disorder. Individuals with a dual diagnosis require an integrated treatment plan that addresses both disorders as interconnected mental health issues. According to the National Survey on Drug Use and Health, 45 percent of people with addiction have a co-occurring mental health disorder. We will feature providers who have integrated services and support across systems, and their lessons learned.

4:30pm – 5:15pm
Mental Wellbeing: A Holistic Approach to Workplace Wellness

Personal accountability – the belief in one’s ability to influence the world around them, improve relationships, achieve goals and set their own trajectory in life – an essential and often overlooked element of employee wellbeing. Learn how to transform your organization’s culture for heightened accountability, alignment and engagement, impacting employees’ lives at work… and at home.

5:15pm
End of Day One

Day Two – Tuesday, October 27, 2020

7:15am – 8:00am
7:15am – 8:00am

8:00am – 8:15am
Chairperson’s Remarks

8:15am – 9:00am
Radical Recovery for a Broken System: Bravely Exploring the Need for Innovative Models of Business and Therapeutic Modalities in Behavioral Healthcare

In this lecture, Scott Kiloby will discuss how he disrupted the addiction recovery field by challenging old ways of thinking about mental health and addiction and by developing a unique methodology from a rarely translated school of mindfulness in the East. He is the developer of several unorthodox businesses and several approaches for treating an extremely wide variety of mental illnesses and even chronic pain. Scott’s “Kiloby Inquiries” have proven (through independent outcomes measurements) to be very effective as treatment for many forms of trauma, depression and anxiety. Scott’s approach and philosophy may challenge us in uncomfortable ways but will surely inspire us to think outside the box when it comes to the future of healthcare.

9:00am – 9:45am
Making Behavioral Health Part of Your Workplace Wellness Program

This session will examine how employers can and should address the total health of employee populations by addressing mental health issues and emotional wellness. Topics to be addressed will include:

- Ensuring employees have access to mental health benefits including an employee assistance program (EAP)
- Making behavioral health a priority to enhance employee well-being and boost productivity
- How focusing on addressing behavioral health can reduce costs
- Leveraging telemedicine to offer employees instant access to mental health coaching and educational resources

9:45am – 10:15am
Networking & Refreshments Break

10:15am – 11:00am
Social Determinants of Mental Health

Good mental health is integral to human health and wellbeing. A person’s mental health and many common mental disorders are shaped by various social, economic and physical environments operating at different stages of life. Risk factors for many common mental disorders are heavily associated with social inequalities, whereby the greater the inequality the higher the inequality in risk. This session will examine the importance of social factors in the initiation and maintenance of mental illness and the need for action and effective interventions to improve the conditions of everyday life in order to improve a population’s mental health.

11:00am – 11:45am
Understanding the Genetic Roots of Addiction: Causes and Solutions

Learn how we can determine genetic influencers on predispositions toward various addictive behaviors and mental health conditions. Why are so many individuals falling victim to the chain of addictive behaviors and becoming part of the worst epidemic in the history of the word? The answer is, in part, both genetic and environmental. We will explore the causes and solutions.

11:45am – 12:30pm
How to Manage Pain in Patients with Mental or Behavioral Health Disorders

Managing pain in patients who have mental or behavioral health disorders presents many challenges. Stigma surrounding addiction has detrimental effects on patients with comorbid chronic pain conditions—despite evidence that addiction is a disease with the same genetic transmissibility as many other chronic diseases. Clinical pharmacists play an integral role in educating these patients about appropriate opioid use. This session will feature a clinical pharmacist who will discuss addiction as a chronic disease and how addiction affects treatment.

12:30pm
Conference Concludes

Workshop – Tuesday, October 27, 2020

1:00pm – 3:30pm
The Connection Between Substance Use Disorders and Mental Illness and Treating Co-Occurring Disorders

Many individuals who develop substance use disorders (SUD) are also diagnosed with mental disorders, and vice versa. Multiple national population surveys have found that about half of those who experience a mental illness during their lives will also experience a substance use disorder and vice versa. Many separate and parallel mental health and substance abuse treatment systems do not offer interventions that are accessible, integrated, and tailored for the presence of co-occurrence. This workshop will offer guidance related to treating co-occurring disorders, including training, specific programs, and quality improvement.

Featured Speakers

Chris Williams

Chris Williams

Math and Science Instructional Coach/Lead Educational Consultant

Newton County Schools/EPIC Educators LLC.

Pranav V. Shah, MD

Pranav V. Shah, MD

Department of Psychiatry, Southern California Permanente Medical Group Orange County

Kaiser Permanente

Edwin A. Salsitz, MD, DFASAM

Edwin A. Salsitz, MD, DFASAM

Associate Clinical Professor

Mount Sinai Beth Israel

Claudia P. Rodriguez, MD

Claudia P. Rodriguez, MD

Director of Addiction Services

Brigham and Women’s Faulkner Hospital

Louis A. Amis

Louis A. Amis

Director of Employee Benefits

City of Atlanta

Kathleen Kobernik

Kathleen Kobernik

Senior Health Care Analyst

Blue Cross Blue Shield of Michigan

William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABA, DAAPM

William Morrone, DO, MPH, MS, FAOAAM, ASAM, FACOFP, DABA, DAAPM

Medical Director

Recovery Pathways and the Shiawassee 35th Circuit Drug Court
Assistant Professor of Nursing
Johns Hopkins University
Faculty, Family and Community Medicine
Michigan State University College of Osteopathic Medicine
Assistant Program Director of Family Medicine
Synergy Medical Education Alliance

Alin J. Severance, MD

Alin J. Severance, MD

Associate Medical Director

Community Care Behavioral Health Organization

Dan Scheinkman

Dan Scheinkman

Vice President, Compensation, Benefits, and Well-Being

Freddie Mac

Barbara Steacy

Barbara Steacy

Benefits Senior, Well-Being and Rewards and Recognition

Freddie Mac

Jason Hoch, PharmD

Jason Hoch, PharmD

Clinical Pharmacist-Addiction Medicine, Clinical Assistant Professor of Pharmacy

Geisinger Bloomsburg Hospital

Jennifer Esper

Jennifer Esper

Chief Executive Officer

Esper Treatment Center

Ghazala Nathu, MD, MS, PhD, FACB

Ghazala Nathu, MD, MS, PhD, FACB

Clinical/Molecular Pathology Director, Laboratory Services, Director of Opioid Waterford Medical Clinic

Bassett Healthcare Network – Cobleskill Regional Hospital

Venue

TBA

Sponsors and Exhibitors

Exhibitors

 

Orexo US, Inc. Orexo US, Inc., a specialty pharmaceutical company with a mission to advance the treatment of opioid dependence and support patient care. We recognize opioid dependence is a long standing problem and have made a commitment to advancing evidence based treatment.

 

Deja Skin therapy using micro and magnetic currents, LED light therapy and CBD mineral skin care.

 

FAQ

Are there group discounts available?

  • Yes – Register a group of 3 or more at the same time and receive an additional 10% off the registration fee

Are there discounts for Non-Profit/Government Organizations?

  • Yes – please call us at 800-743-8490 for special pricing

What is the cancellation policy?

  • Cancellations received 3 weeks prior to the event will receive a refund minus the administration fee of $185. Cancellation received less than 3 weeks prior to the event will receive a credit to a future event valid for one year.

Can the registration be transferred to a colleague?

  • Yes – please email us in writing at info@brinetwork.com with the colleague’s name and title

Where can I find information on the venue/accommodations?

  • Along with your registration receipt you will receive information on how to make your hotel reservations. You can also visit individual event page for specific hotel information. The conference fee does not include the cost of accommodations.

What is the suggested dress code?

  • Business casual. Meeting rooms can sometimes be cold so we recommend a sweater or light jacket

Request Brochure

Register Your Team Today!

Register Now

Special Discount Offer – Register by July 31st and Save an Additional $200 off the registration fee – mention Promo Code WB200!

Ask A Question

Be A Thought Leader And Share!

Pin It on Pinterest